
(Credit: Karolina Grabowska from Pexels)
Your Morning Coffee Is Reshaping Your Gut, and Your Brain May Be Along for the Ride
In A Nutshell
- Habitual coffee drinking is associated with a measurably different gut microbiome, with specific bacterial strains more or less abundant in coffee drinkers compared to non-drinkers.
- Many of coffee’s effects on gut bacteria and brain-related chemical compounds appear to be driven by plant-based antioxidants in coffee, not caffeine alone.
- Coffee drinkers scored higher on impulsivity and emotional reactivity; both declined when coffee was removed and dropped further when it was reintroduced.
- Caffeinated and decaffeinated coffee showed different benefits: caffeinated was linked to lower anxiety, while decaf was associated with better sleep, memory scores, and physical activity.
For millions of people, coffee is the first thing that happens in the morning. It turns out something is happening back. A new study finds that habitual coffee drinking is associated with changes in the community of microbes living in the gut, shifts in certain chemical compounds those microbes produce, and differences in behavioral traits such as impulsivity and emotional reactivity. Many of those associations hold even when caffeine is taken out of the picture entirely.
Published in Nature Communications, the research is one of the most thorough investigations to date of how coffee relates to the gut-brain axis, a two-way communication pathway between the trillions of bacteria in the digestive tract and the brain. By tracking healthy adults through periods of coffee drinking, forced abstinence, and controlled reintroduction of either caffeinated or decaffeinated coffee, the team mapped connections between morning coffee habits and measurable shifts in gut bacteria, immune function, brain-related chemicals, and cognitive performance.
Notably, many of those associations had nothing to do with caffeine. When participants resumed decaffeinated coffee, their gut microbes still responded and memory test scores improved, though the authors caution that practice effects from repeating the same tasks may partly explain that gain. Coffee, it turns out, is a far more interesting player in human health than its most famous ingredient would suggest.
62 Adults, Three Phases, and a Two-Week Coffee Ban
Sixty-two healthy adults participated, split evenly into 31 habitual coffee drinkers and 31 non-coffee drinkers, all recruited through University College Cork in Ireland. Groups were similar in age, education, alcohol use, and estimated IQ, and no major dietary differences were found between them.
The study ran in three phases. First, researchers compared the two groups at baseline, collecting stool, urine, and blood samples alongside an extensive battery of questionnaires and cognitive tests. Coffee drinkers then gave up all coffee for two weeks. Those same participants were then randomly assigned to reintroduce either caffeinated or decaffeinated coffee for 21 days. Sixteen received caffeinated and 15 received decaffeinated. Gut bacteria were analyzed through genetic sequencing of stool samples throughout all three phases.

Coffee Drinkers Carry a Different Gut Microbiome
Coffee drinkers harbored a noticeably different microbial community compared to non-drinkers. Specific bacterial strains were significantly more abundant in the guts of coffee drinkers, while other species were more prevalent in non-drinkers. Overall gut diversity did differ between the two groups at baseline, though it stayed relatively stable during the withdrawal and reintroduction phases, suggesting coffee’s influence targets specific populations rather than overhauling the entire ecosystem.
When coffee drinkers stopped for two weeks, some bacterial populations shifted back toward levels seen in non-drinkers. When coffee was reintroduced, both caffeinated and decaffeinated versions triggered microbial changes, pointing to plant-based compounds in coffee called phenolic acids, natural antioxidants found throughout the plant, as likely drivers rather than caffeine alone.
On the metabolite side, coffee drinkers had lower stool levels of GABA, a compound linked to brain signaling, along with two other compounds recently associated with cognitive health and gut lining protection. All three can be produced by gut bacteria. Caffeine-related compounds dropped during abstinence and responded differently depending on coffee type upon reintroduction. Phenolic compounds rose in both groups regardless of caffeine content, with wide person-to-person variation suggesting individual gut bacteria play a role in how those plant chemicals are processed.
Decaf Drinkers Slept Better, Caffeinated Drinkers Felt Less Anxious
On the behavioral side, coffee drinkers scored significantly higher on impulsivity and emotional reactivity measures compared to non-drinkers. After two weeks without coffee, both scores declined. When coffee was reintroduced, impulsivity dropped in both groups, while emotional reactivity decreased more clearly in the decaffeinated group across some measures.
Caffeinated coffee showed distinct associations: participants in that group reported reduced anxiety and psychological distress. Decaffeinated coffee drinkers saw improvements in memory test scores, sleep quality, and physical activity that the caffeinated group did not, though researchers note some cognitive gains may partly reflect task repetition. On a learning task, the decaffeinated group also showed significantly fewer errors.
Cortisol, the body’s primary stress hormone, was similar between groups at baseline and did not significantly change during withdrawal in this study. During reintroduction, the caffeinated group showed lower morning cortisol, while the decaffeinated group’s levels held steady.
Blood markers added another layer. At baseline, coffee drinkers had lower CRP, a marker of inflammation, and higher levels of an anti-inflammatory molecule called IL-10, suggesting a possible protective role. When coffee was withdrawn, CRP and another inflammatory marker rose. When immune cells were exposed to a bacterial toxin in the lab, both caffeinated and decaffeinated coffee were associated with a significantly reduced IL-6 response after reintroduction, again pointing to compounds beyond caffeine as contributors.
When researchers built statistical models connecting microbial species, chemical compounds, and cognitive or behavioral outcomes, nine compounds emerged as central hubs, each linked to multiple bacterial species and to scores on cognitive and behavioral tests.
The data paints a picture in which coffee consumption is associated with specific microbial shifts, and those shifts correlate with changes in the gut’s chemical environment. Those chemicals are in turn linked to measurable differences in how people think and respond emotionally. For a beverage most people drink on autopilot, it appears to be doing quite a lot beneath the surface.
Disclaimer: This article is based on a published peer-reviewed study. It is intended for informational purposes only and does not constitute medical advice. Results are observational and associative; they do not establish that coffee causes any of the health, behavioral, or cognitive outcomes described. Individual responses to coffee may vary. Consult a qualified healthcare provider before making any changes to your diet or health routine.
Paper Notes
Limitations
The study had several notable limitations. It did not directly measure stool transit time, relying instead on surrogate markers such as the Bristol Stool Scale and a gastrointestinal visual analogue scale, the latter of which has not been validated in healthy individuals. Baseline caffeine withdrawal in the non-coffee-drinking group may have influenced group differences, though the amount of caffeine given up was likely below the threshold for withdrawal symptoms. The sample lacked sufficient ethnic diversity to analyze differences across groups, with the non-coffee-drinking group including more participants from non-Caucasian backgrounds. The study may not have been sufficiently powered to detect small to medium effect sizes for outcomes beyond the primary gut microbiome hypothesis. Some cognitive improvements observed may partly reflect task repetition rather than a true treatment effect.
Funding and Disclosures
Funding was provided by the Institute for Scientific Information on Coffee (ISIC), APC Microbiome Ireland through Science Foundation Ireland (grant no. 12/RC/2273_P2), the European Research Council under the Horizon 2020 program (PREDICT-CARE project, grant no. 950050), and the Italian Ministry of University and Research via the National Recovery and Resilience Plan (Project code PE00000003). Competing interests were disclosed: senior author John F. Cryan has received research funding from Nutricia, DuPont/IFF, and Nestlé and has spoken at conferences organized by Bromotech, Yakult, and Nestlé. Co-author Gerard Clarke has received honoraria and research funding from several food and pharmaceutical companies. Full disclosures appear in the published paper.
Publication Details
Title: Habitual coffee intake shapes the gut microbiome and modifies host physiology and cognition | Authors: Serena Boscaini, Thomaz F. S. Bastiaanssen, Gerard M. Moloney, and colleagues at APC Microbiome Ireland, University College Cork, and the University of Parma | Journal: Nature Communications | Published: April 21, 2026 | DOI: https://doi.org/10.1038/s41467-026-71264-8 | Clinical Trial Registrations: NCT05927038 and NCT05927103







